Susquehanna International Group’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$873K Sell
15,878
-75,602
-83% -$4.16M ﹤0.01% 3474
2025
Q1
$6.47M Buy
91,480
+506
+0.6% +$35.8K ﹤0.01% 962
2024
Q4
$5.98M Sell
90,974
-19,149
-17% -$1.26M ﹤0.01% 995
2024
Q3
$7.74M Buy
110,123
+73,045
+197% +$5.13M ﹤0.01% 778
2024
Q2
$3.05M Sell
37,078
-639,608
-95% -$52.7M ﹤0.01% 1366
2024
Q1
$59.1M Buy
676,686
+417,128
+161% +$36.4M 0.01% 129
2023
Q4
$25M Sell
259,558
-55,190
-18% -$5.32M ﹤0.01% 328
2023
Q3
$27.8M Sell
314,748
-122,730
-28% -$10.9M 0.01% 327
2023
Q2
$37.9M Buy
437,478
+89,563
+26% +$7.76M 0.01% 245
2023
Q1
$33.8M Buy
347,915
+155,060
+80% +$15.1M 0.01% 288
2022
Q4
$20M Sell
192,855
-80,282
-29% -$8.31M 0.01% 351
2022
Q3
$23.2M Buy
273,137
+264,455
+3,046% +$22.4M 0.01% 242
2022
Q2
$720K Sell
8,682
-87,429
-91% -$7.25M ﹤0.01% 2869
2022
Q1
$7.41M Sell
96,111
-24,194
-20% -$1.87M ﹤0.01% 891
2021
Q4
$10.6M Sell
120,305
-102,090
-46% -$9.02M ﹤0.01% 740
2021
Q3
$17.2M Buy
222,395
+96,560
+77% +$7.46M ﹤0.01% 532
2021
Q2
$10.5M Sell
125,835
-296,140
-70% -$24.7M ﹤0.01% 796
2021
Q1
$31.9M Buy
421,975
+57,791
+16% +$4.36M 0.01% 323
2020
Q4
$31.9M Buy
364,184
+158,217
+77% +$13.9M 0.01% 299
2020
Q3
$15.7M Buy
205,967
+45,096
+28% +$3.43M ﹤0.01% 382
2020
Q2
$19.8M Sell
160,871
-51,873
-24% -$6.4M ﹤0.01% 313
2020
Q1
$18M Sell
212,744
-383,070
-64% -$32.4M 0.01% 248
2019
Q4
$50.4M Buy
595,814
+144,939
+32% +$12.3M 0.01% 154
2019
Q3
$30.4M Buy
450,875
+309,777
+220% +$20.9M 0.01% 177
2019
Q2
$12.1M Buy
+141,098
New +$12.1M ﹤0.01% 351
2019
Q1
Hold
0
3118
2018
Q4
Hold
0
3726
2018
Q3
Sell
-193,029
Closed -$18.2M 3432
2018
Q2
$18.2M Buy
193,029
+138,975
+257% +$13.1M 0.01% 235
2018
Q1
$4.38M Sell
54,054
-148,539
-73% -$12M ﹤0.01% 558
2017
Q4
$18.1M Buy
202,593
+186,042
+1,124% +$16.6M 0.01% 220
2017
Q3
$1.54M Sell
16,551
-102,277
-86% -$9.52M ﹤0.01% 1289
2017
Q2
$10.8M Buy
118,828
+17,288
+17% +$1.57M ﹤0.01% 297
2017
Q1
$8.91M Sell
101,540
-223,449
-69% -$19.6M ﹤0.01% 297
2016
Q4
$26.9M Sell
324,989
-37,642
-10% -$3.12M 0.01% 115
2016
Q3
$33.6M Buy
362,631
+99,211
+38% +$9.18M 0.02% 72
2016
Q2
$20.5M Buy
263,420
+90,022
+52% +$7M 0.01% 117
2016
Q1
$14.3M Buy
173,398
+74,518
+75% +$6.15M 0.01% 244
2015
Q4
$10.4M Buy
98,880
+51,538
+109% +$5.4M ﹤0.01% 421
2015
Q3
$4.99M Sell
47,342
-177,574
-79% -$18.7M ﹤0.01% 853
2015
Q2
$30.8M Buy
224,916
+67,316
+43% +$9.21M 0.01% 230
2015
Q1
$19.6M Buy
157,600
+116,980
+288% +$14.6M 0.01% 273
2014
Q4
$3.67M Buy
40,620
+26,292
+184% +$2.38M ﹤0.01% 1271
2014
Q3
$1.03M Sell
14,328
-52,189
-78% -$3.77M ﹤0.01% 2320
2014
Q2
$4.14M Buy
66,517
+27,690
+71% +$1.72M ﹤0.01% 1149
2014
Q1
$2.65M Sell
38,827
-71,911
-65% -$4.9M ﹤0.01% 1332
2013
Q4
$7.78M Sell
110,738
-64,145
-37% -$4.51M ﹤0.01% 779
2013
Q3
$12.6M Sell
174,883
-31,008
-15% -$2.24M 0.01% 428
2013
Q2
$11.5M Buy
+205,891
New +$11.5M 0.01% 461